Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.

Literature DB >> 17371818

Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.

Margaret Ip¹, Shirley S L Chau, Fang Chi, Edmund S C Cheuk, Helen Ma, Raymond W M Lai, Paul K Chan.

Abstract

Of 1,388 Streptococcus pneumoniae isolates collected from 2000 to 2005, 10.5% had a ciprofloxacin MIC of >/=4.0 mug/ml and 1.6% (range, 0.8% to 4.3% per year) had a levofloxacin MIC of >/=4.0 mug/ml. Molecular characterization indicated that fluoroquinolone resistance occurred independently in our prevalent Spain(23F)-1 clone, expressing serotypes 23F, 19F, and 14. Rates of resistance to levofloxacin in S. pneumoniae have remained stable at a Hong Kong hospital.

Entities: Chemical Species

Mesh：

Substances：

Year: 2007 PMID： 17371818 PMCID： PMC1891361 DOI： 10.1128/AAC.00139-07

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

22 in total

1. Introduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong Kong.

Authors: Margaret Ip; Donald J Lyon; Raymond W H Yung; Lily Tsang; Augustine F B Cheng
Journal: J Clin Microbiol Date: 2002-04 Impact factor: 5.948

2. Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong.

Authors: Ian Morrissey; David J Farrell; Sarah Bakker; Sylvie Buckridge; David Felmingham
Journal: Antimicrob Agents Chemother Date: 2003-04 Impact factor: 5.191

3. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.

Authors: S S Richter; K P Heilmann; S E Beekmann; N J Miller; C L Rice; G V Doern
Journal: Clin Infect Dis Date: 2004-12-21 Impact factor: 9.079

4. Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns.

Authors: L M Hall; R A Whiley; B Duke; R C George; A Efstratiou
Journal: J Clin Microbiol Date: 1996-04 Impact factor: 5.948

Review 5. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948

6. Evidence of clonal dissemination of multidrug-resistant Streptococcus pneumoniae in Hong Kong.

Authors: M Ip; D J Lyon; R W Yung; C Chan; A F Cheng
Journal: J Clin Microbiol Date: 1999-09 Impact factor: 5.948

Review 7. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.

Authors: Jeffrey D Fuller; Donald E Low
Journal: Clin Infect Dis Date: 2005-05-26 Impact factor: 9.079

8. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.

Authors: Kristen N Schurek; Heather J Adam; Christine G Siemens; Chris J Hoban; Daryl J Hoban; George G Zhanel
Journal: J Antimicrob Chemother Date: 2005-08-26 Impact factor: 5.790

9. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

Authors: Gary V Doern; Sandra S Richter; Ashley Miller; Norma Miller; Cassie Rice; Kristopher Heilmann; Susan Beekmann
Journal: Clin Infect Dis Date: 2005-06-07 Impact factor: 9.079

10. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.

Authors: Heather J Smith; Michael Walters; Tamiko Hisanaga; George G Zhanel; Daryl J Hoban
Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191

9 in total

1. Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.

Authors: Arnau Domenech; Jose M Tirado-Vélez; Asunción Fenoll; Carmen Ardanuy; Jose Yuste; Josefina Liñares; Adela G de la Campa
Journal: Antimicrob Agents Chemother Date: 2014-02-10 Impact factor: 5.191

2. Reactive Oxygen Species Production Is a Major Factor Directing the Postantibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.

Authors: M T García; M V Valenzuela; M J Ferrándiz; A G de la Campa
Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191

3. Childhood pneumococcal diseases and serotypes: can vaccines protect?

Authors: Kam Lun Hon; Margaret Ip; Kenneth Lee; Edmund Anthony Nelson; Ka Ho Eric Shea; Yiu Sang Tony Yuen; Ting Fan Leung
Journal: Indian J Pediatr Date: 2010-09-16 Impact factor: 1.967

4. Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.

Authors: M J Ferrándiz; A J Martín-Galiano; C Arnanz; T Zimmerman; A G de la Campa
Journal: Antimicrob Agents Chemother Date: 2015-11-02 Impact factor: 5.191

Review 5. Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors: Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal: Clin Microbiol Rev Date: 2016-07 Impact factor: 26.132